LINC vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

LINC

30.4
AI Score
VS
LINC Wins

UTI

45.4
AI Score

Investment Advisor Scores

LINC

30score
Recommendation
AVOID NEW MONEY

UTI

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LINC UTI Winner
Forward P/E 26.0417 27.248 LINC
PEG Ratio 1.7369 1.8142 LINC
Revenue Growth 22.4% 7.2% LINC
Earnings Growth 20.0% -78.9% LINC
Tradestie Score 30.4/100 45.4/100 UTI
Profit Margin 4.0% 3.9% LINC
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD UTI

Relative Price Performance (Last 90 Days)

LINC 1M: -12.3% · 3M: -48.4% UTI 1M: +1.9% · 3M: -46.2%

Current Technical Phase

LINC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -23.0%), weak momentum, RSI 29

RSI (14): 28.6 · Price: $21.25

UTI

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -24.3%) with fading momentum, RSI 48

RSI (14): 48.4 · Price: $20.80

Fundamentals Snapshot

Metric LINC UTI
Market Cap — —
Forward P/E 20.3 28.3
Trailing P/E 29.7 33.8
Revenue (TTM) — —
Revenue Growth 0.2% 0.1%
Gross Margin 0.6% 0.6%
Operating Margin 0.0% 0.0%
EPS 0.73 0.61
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, LINC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.